Lubberink M - Search Results

1

Evaluation of Penalized-Likelihood Estimation Reconstruction on a Digital Time-of-Flight PET/CT Scanner for ¹⁸F-FDG Whole-Body Examinations.

Lindström E, Sundin A, Trampal C, Lindsjö L, Ilan E, Danfors T, Antoni G, Sörensen J, Lubberink M. Lindström E, et al. Among authors: lubberink m. J Nucl Med. 2018 Jul;59(7):1152-1158. doi: 10.2967/jnumed.117.200790. Epub 2018 Feb 15. J Nucl Med. 2018. PMID: 29449445 Free article.

2

Kinetic analysis of 52Fe-labelled iron(III) hydroxide-sucrose complex following bolus administration using positron emission tomography.

Beshara S, Lundqvist H, Sundin J, Lubberink M, Tolmachev V, Valind S, Antoni G, Långström B, Danielson BG. Beshara S, et al. Among authors: lubberink m. Br J Haematol. 1999 Feb;104(2):288-95. doi: 10.1046/j.1365-2141.1999.01170.x. Br J Haematol. 1999. PMID: 10050710 Free article.

3

Pharmacokinetics and red cell utilization of iron(III) hydroxide-sucrose complex in anaemic patients: a study using positron emission tomography.

Beshara S, Lundqvist H, Sundin J, Lubberink M, Tolmachev V, Valind S, Antoni G, Långström B, Danielson BG. Beshara S, et al. Among authors: lubberink m. Br J Haematol. 1999 Feb;104(2):296-302. doi: 10.1046/j.1365-2141.1999.01179.x. Br J Haematol. 1999. PMID: 10050711 Free article.

4

Kinetics of 76Br-labeled anti-CEA antibodies in pigs; aspects of dosimetry and PET imaging properties.

Lövqvist A, Lundqvist H, Lubberink M, Tolmachev V, Carlsson J, Sundin A. Lövqvist A, et al. Among authors: lubberink m. Med Phys. 1999 Feb;26(2):249-58. doi: 10.1118/1.598512. Med Phys. 1999. PMID: 10076983

5

Positron emission tomography and radioimmunotargeting--general aspects.

Lundqvist H, Lubberink M, Tolmachev V, Lövqvist A, Sundin A, Beshara S, Bruskin A, Carlsson J, Westlin JE. Lundqvist H, et al. Among authors: lubberink m. Acta Oncol. 1999;38(3):335-41. doi: 10.1080/028418699431410. Acta Oncol. 1999. PMID: 10380825

6

Positron emission tomography and radioimmunotargeting--aspects of quantification and dosimetry.

Lubberink M, Lundqvist H, Westlin JE, Tolmachev V, Schneider H, Lövqvist A, Sundin A, Carlsson J. Lubberink M, et al. Acta Oncol. 1999;38(3):343-9. doi: 10.1080/028418699431429. Acta Oncol. 1999. PMID: 10380826

7

110mIn-DTPA-D-Phe1-octreotide for imaging of neuroendocrine tumors with PET.

Lubberink M, Tolmachev V, Widström C, Bruskin A, Lundqvist H, Westlin JE. Lubberink M, et al. J Nucl Med. 2002 Oct;43(10):1391-7. J Nucl Med. 2002. PMID: 12368379 Free article.

8

Comparative biodistribution of the radiohalogenated (Br, I and At) antibody A33. Implications for in vivo dosimetry.

Orlova A, Höglund J, Lubberink M, Lebeda O, Gedda L, Lundqvist H, Tolmachev V, Sundin A. Orlova A, et al. Among authors: lubberink m. Cancer Biother Radiopharm. 2002 Aug;17(4):385-96. doi: 10.1089/108497802760363187. Cancer Biother Radiopharm. 2002. PMID: 12396703

9

Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography.

Beshara S, Sörensen J, Lubberink M, Tolmachev V, Långström B, Antoni G, Danielson BG, Lundqvist H. Beshara S, et al. Among authors: lubberink m. Br J Haematol. 2003 Mar;120(5):853-9. doi: 10.1046/j.1365-2141.2003.03590.x. Br J Haematol. 2003. PMID: 12614222 Free article.

10

Quantitative comparison of analytic and iterative reconstruction methods in 2- and 3-dimensional dynamic cardiac 18F-FDG PET.

Lubberink M, Boellaard R, van der Weerdt AP, Visser FC, Lammertsma AA. Lubberink M, et al. J Nucl Med. 2004 Dec;45(12):2008-15. J Nucl Med. 2004. PMID: 15585474 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

255 results

Search Page

Filters